[{"orgOrder":0,"company":"Novozymes","sponsor":"Estimates OY","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"DENMARK","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Bacillus Velezensis DSM 33864","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Novozymes \/ Estimates OY","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ Estimates OY"},{"orgOrder":0,"company":"Novozymes","sponsor":"University of Aarhus","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"DENMARK","productType":"Enzyme","year":"2021","type":"Inapplicable","leadProduct":"Enzyme","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Novozymes \/ University of Aarhus","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ University of Aarhus"},{"orgOrder":0,"company":"Novozymes","sponsor":"Beijing Children's Hospital | Baoding Children's Hospital | Xuzhou Children Hospital | Chengdu Women's and Children's Central Hospital | Children's Hospital of Heibei Province | Beijing Clinical Service Center","pharmaFlowCategory":"DU","therapeuticArea":"Pharmacology\/Toxicology","country":"DENMARK","productType":"Probiotic","year":"2021","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum DSM 33464","moa":"Undisclosed","graph1":"Pharmacology\/Toxicology","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Toxicology","amount2New":0,"dosageForm":"Sachet","sponsorNew":"Novozymes \/ Beijing Children's Hospital | Baoding Children's Hospital | Xuzhou Children Hospital | Chengdu Women's and Children's Central Hospital | Children's Hospital of Heibei Province | Beijing Clinical Service Center","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ Beijing Children's Hospital | Baoding Children's Hospital | Xuzhou Children Hospital | Chengdu Women's and Children's Central Hospital | Children's Hospital of Heibei Province | Beijing Clinical Service Center"},{"orgOrder":0,"company":"Novozymes","sponsor":"Universidad Iberoamericana A.C., Mexico | Linus Biotechnology Inc","pharmaFlowCategory":"DU","therapeuticArea":"Pharmacology\/Toxicology","country":"DENMARK","productType":"Probiotic","year":"2022","type":"Inapplicable","leadProduct":"Lactobacillus Plantarum DSM 33464","moa":"Undisclosed","graph1":"Pharmacology\/Toxicology","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Toxicology","amount2New":0,"dosageForm":"Sachet","sponsorNew":"Novozymes \/ Universidad Iberoamericana A.C., Mexico | Linus Biotechnology Inc","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ Universidad Iberoamericana A.C., Mexico | Linus Biotechnology Inc"},{"orgOrder":0,"company":"Novozymes","sponsor":"Novozymes","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"IRELAND","productType":"Probiotic","year":"2023","type":"Inapplicable","leadProduct":"Limosilactobacillus Reuteri","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Novozymes \/ Novozymes","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ Novozymes"},{"orgOrder":0,"company":"Novozymes","sponsor":"Biofortis M\u00e9rieux Nutriscience","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"DENMARK","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"NZ-GHMH-01","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Novozymes \/ Biofortis M\u00e9rieux Nutriscience","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ Biofortis M\u00e9rieux Nutriscience"},{"orgOrder":0,"company":"Novozymes","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"DENMARK","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Polyphenol Oxidase","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Novozymes \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ Undisclosed"},{"orgOrder":0,"company":"Novozymes","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"DENMARK","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Novozymes \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ Undisclosed"},{"orgOrder":0,"company":"Novozymes","sponsor":"Analyze & Realize","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"DENMARK","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Novozymes \/ Analyze & Realize","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ Analyze & Realize"},{"orgOrder":0,"company":"Novozymes","sponsor":"University of Aarhus","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"DENMARK","productType":"Undisclosed","year":"2023","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Undisclosed","graph3":"Novozymes","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Novozymes \/ University of Aarhus","highestDevelopmentStatusID":"1","companyTruncated":"Novozymes \/ University of Aarhus"}]

Find Clinical Drug Pipeline Developments & Deals by Novozymes

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Dental Plaque.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          November 21, 2023

                          Lead Product(s) : Undisclosed

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Undisclosed

                          Sponsor : University of Aarhus

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Lactose Intolerance.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          October 30, 2023

                          Lead Product(s) : Undisclosed

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Undisclosed

                          Sponsor : Analyze & Realize

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Details : Limosilactobacillus Reuteri is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Obesity.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          July 12, 2023

                          Lead Product(s) : Limosilactobacillus Reuteri

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Undisclosed

                          Recipient : University College Cork

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Details : Bacillus Velezensis DSM 33864 is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Clostridium Infections.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          November 04, 2022

                          Lead Product(s) : Bacillus Velezensis DSM 33864

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : Estimates OY

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Dental Plaque.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          October 14, 2022

                          Lead Product(s) : Undisclosed

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Undisclosed

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Lead Product(s) : Lactobacillus Plantarum DSM 33464

                          Therapeutic Area : Pharmacology/Toxicology

                          Study Phase : Undisclosed

                          Sponsor : Universidad Iberoamericana A.C., Mexico | Linus Biotechnology Inc

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Lactobacillus Plantarum DSM 33464 is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Lead Poisoning.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          August 18, 2022

                          Lead Product(s) : Lactobacillus Plantarum DSM 33464

                          Therapeutic Area : Pharmacology/Toxicology

                          Highest Development Status : Undisclosed

                          Sponsor : Universidad Iberoamericana A.C., Mexico | Linus Biotechnology Inc

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Details : Polyphenol Oxidase is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Halitosis.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          June 10, 2022

                          Lead Product(s) : Polyphenol Oxidase

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Undisclosed

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Details : This is a Enzyme drug candidate, which is currently being evaluated in clinical studies for the treatment of Dental Plaque.

                          Product Name : Undisclosed

                          Product Type : Enzyme

                          Upfront Cash : Inapplicable

                          October 07, 2021

                          Lead Product(s) : Enzyme

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Undisclosed

                          Sponsor : University of Aarhus

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Lead Product(s) : Lactobacillus Plantarum DSM 33464

                          Therapeutic Area : Pharmacology/Toxicology

                          Study Phase : Undisclosed

                          Sponsor : Beijing Children's Hospital | Baoding Children's Hospital | Xuzhou Children Hospital | Chengdu Women's and Children's Central Hospital | Children's Hospital of Heibei Province | Beijing Clinical Service Center

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Lactobacillus Plantarum DSM 33464 is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of Lead Poisoning.

                          Product Name : Undisclosed

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          May 18, 2021

                          Lead Product(s) : Lactobacillus Plantarum DSM 33464

                          Therapeutic Area : Pharmacology/Toxicology

                          Highest Development Status : Undisclosed

                          Sponsor : Beijing Children's Hospital | Baoding Children's Hospital | Xuzhou Children Hospital | Chengdu Women's and Children's Central Hospital | Children's Hospital of Heibei Province | Beijing Clinical Service Center

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          PREP
                          Not Confirmed
                          PREP
                          Not Confirmed

                          Details : NZ-GHMH-01 is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Prediabetic State.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          February 23, 2021

                          Lead Product(s) : NZ-GHMH-01

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Undisclosed

                          Sponsor : Biofortis Mérieux Nutriscience

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank